Industry Insights

• 
  Has the booming PD-1 inhibitor reached its limit? Krebs Qin
  October 18, 2024
  In the field of oncology, Opdivo and Keytruda, as core immunotherapy agents for PD-1 inhibitors, have delivered significant survival benefits to patients with a variety of cancers.
• 
  Future Prospects of Small Molecule and Monoclonal Antibody Drugs in Oncology and Immunology Krebs Qin
  October 18, 2024
  Specifically, there is a balance between small molecules and monoclonal antibody drugs (mAbs) in the realm of oncology super blockbuster drugs, while immunology appears dominated by monoclonal antibodies and protein-based treatments.
• 
  What Sparks Will Come from the Collaboration Between CSPC and AstraZeneca? wan
  October 18, 2024
  On October 7, 2024, CSPC Pharmaceutical Group Co., Ltd entered into a significant collaboration agreement with AstraZeneca, creating quite a stir in the pharmaceutical industry.

• 
  Charting the Course: A Deep Dive into Pharmaceutical Product Lifecycle Management Shruti Talashi
  November 21, 2024
  At every stage of the product lifecycle, pharmaceutical companies are subject to strict regulations and must maintain compliance with local governing bodies.

• 
  AI in Pharmacovigilance: Predicting & Preventing Drug Risks Nurah Ekhlaque
  November 19, 2024
• 
  Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases PharmaSources
  October 15, 2024
• 
  Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization PharmaSources
  October 15, 2024
  Eleva, a pioneer in unlocking difficult-to-produce biologics based on a breakthrough manufacturing platform, announced today the appointment of Dr. Elisabeth Lackner to its Supervisory Board.

• 
  Research and Application of Artemisia Argyi Xiaonisha
  August 12, 2024
  Mugwort, also known as fragrant mugwort or Artemisia argyi, is a herbaceous plant belonging to the Compositae family.
• 
  Research Progress on the Application of Biologics in Pediatric Asthma Xiaomichong
  July 19, 2024
• 
  Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives Xiaomichong
  July 19, 2024

• 
  What companies are developing CNS drugs in China? ChatGTP/PharmaSources
  November 08, 2023
  Several pharmaceutical and biotechnology companies in China are actively involved in the research and development of Central Nervous System (CNS) drugs.